Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources
DCP Consortia for Early Phase Trials

Guide to DCP Study Close-Out
Milestone 6: Final Manuscript Submission

Close-out Tasks appearing under each milestone are generally initiated in the same timeframe. Click on the Timing Reminders and Forms & Resources tabs for more information.

View All

  • Ensure the Protocol PI and/or CLO PI submit(s) the final manuscript to the DCP-Protocol Information Office, DCP Medical Monitor, and DCP COR per the CLO contract.
  • Ensure that any remaining study data not included in the final SAS dataset for analysis are sent to DCP.
  • The final manuscript is due to the DCP Medical Monitor, DCP COR, and the DCP-Protocol Information Office within 60 calendar days of study completion, or as specified in the CLO’s contract.
  • Any remaining data, including biomarker and other research laboratory reports, should be sent to DCP within 90 calendar days following completion of the study, or as specified in the CLO’s contract.

Questions? Contact the DCP Help Desk at or (844) 901-4357.

Key to common acronyms: DCP Consortia Acronym List, (doc 61kb)

Provide feedback on the Guide to DCP Study Close-Out.

Back to top